Jiade Yu, MD
Pediatric Dermatology · Boston, MANPI 1538421961
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,170 of the $69,748 with a category attached, or 80.5%. 10 manufacturers reported payments, led by LEO Pharma Inc. at 31.6% of the total.
Across 57 payments — averaging $1223.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$22K
- Sanofi$20K
- Arcutis Biotherapeutics, Inc.$9K
- Incyte Corporation$7K
- Dermavant Sciences, Inc.$4K
- Allerderm Laboratories$3K
- plus $4K from 4 others
Across 25 payments — averaging $3307.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$34K
- AbbVie$28K
- Incyte Corporation$19K
- Regeneron$1K
What the payments were for
- Consulting fees$56,17081%
- Speaking & faculty fees$7,38411%
- Travel & lodging$2,2543%
- Food & beverage$1,4162%
- Education$2,5254%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 14 | $22,051 |
| Sanofi | 11 | $20,223 |
| Arcutis Biotherapeutics, Inc. | 8 | $9,485 |
| Incyte Corporation | 13 | $7,103 |
| Dermavant Sciences, Inc. | 1 | $3,700 |
| Allerderm Laboratories | 3 | $3,365 |
| Janssen Scientific Affairs, LLC | 3 | $1,954 |
| Irhythm Technologies, Inc. | 2 | $1,750 |
| Johnson & Johnson | 1 | $85 |
| AbbVie | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$10,679
- OPZELURA$6,777
- ANZUPGO$5,070
- ZORYVE$3,750
- VTAMA$3,700
- ZIO XT Patch$1,750
- Zio monitor$1,250
How this compares
Too few pediatric dermatology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 56 | $247,467 |
| Dupixent PenDupilumab | 59 | $200,262 |
| Humira PenAdalimumab | 12 | $82,594 |
| Tacrolimus | 19 | $3,916 |
| Clobetasol Propionate | 34 | $2,585 |
| Fluocinonide | 19 | $968 |
| Triamcinolone Acetonide | 43 | $702 |
| Ketoconazole | 32 | $436 |
| MethotrexateMethotrexate Sodium | 20 | $300 |
| Prednisone | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other pediatric dermatology in Boston
- Vimal PrajapatiBoston$19K
- Jennifer HuangBoston$7K
- Jennifer TanBoston$924
- Tina HoBoston$848
- Elena HawrylukBoston$147
- Sarah ServattalabBoston$115
- Kristen CoreyBoston$46
- Meryem SafoineBoston$26
- Pierre-Olivier GrenierBoston$26
- Marilyn LiangBoston$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.